{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:23:37Z","timestamp":1793291017791,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.kint.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T17:45:16Z","timestamp":1728582316000},"page":"1146-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-6005","authenticated-orcid":false,"given":"Eugene Yu-hin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5768-2100","authenticated-orcid":false,"given":"Ellen L.M.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naureen","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-5326","authenticated-orcid":false,"given":"Andrea","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-1359","authenticated-orcid":false,"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-1417","authenticated-orcid":false,"given":"Chang-Yien","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-3712","authenticated-orcid":false,"given":"Anna","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakysa","family":"Hooman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Sydney","family":"Hopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ikram","family":"I","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-0051","authenticated-orcid":false,"given":"Dmytro D.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprita","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison Lap-tak","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Camargo Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subal Kumar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0702-4932","authenticated-orcid":false,"given":"Larisa","family":"Prikhodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem H.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-092X","authenticated-orcid":false,"given":"Rajiv","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Tomari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-1959","authenticated-orcid":false,"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Kim","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8179-8293","authenticated-orcid":false,"given":"Desmond Yat-hin","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-6221","authenticated-orcid":false,"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10157-016-1313-5","article-title":"Rituximab for nephrotic syndrome in children","volume":"21","author":"Iijima","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.2012.238","article-title":"Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome","volume":"82","author":"Gulati","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","article-title":"Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial","volume":"53","author":"Choudhry","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.kint.2023.02.022","article-title":"A\u00a0multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants","volume":"103","author":"Malakasioti","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/nep.14007","article-title":"Demographics and long-term outcomes of children with end-stage kidney disease: a 20-year territory-wide study","volume":"27","author":"Chan","year":"2022","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-017-3649-9","article-title":"Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease","volume":"33","author":"Chan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s00467-022-05828-3","article-title":"Outcomes and perception of cloud-based remote patient monitoring in children receiving automated peritoneal dialysis: a prospective study","volume":"38","author":"Chan","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00467-020-04484-9","article-title":"Left ventricular stiffness in paediatric patients with end-stage kidney disease","volume":"35","author":"Choi","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","article-title":"Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes","volume":"97","author":"Chan","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00467-020-04609-0","article-title":"Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen","volume":"36","author":"Chan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Use of rituximab in childhood idiopathic nephrotic syndrome","volume":"33","author":"Chan","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2022.05.013","article-title":"Clinical factors and adverse kidney outcomes in children with antineutrophil cytoplasmic antibody\u2013associated glomerulonephritis","volume":"81","author":"Marlais","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","article-title":"Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis","volume":"8","author":"Chan","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1007\/s00467-023-06025-6","article-title":"Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis","volume":"38","author":"Chan","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40272-023-00609-3","article-title":"Managing lupus nephritis in children and adolescents","volume":"26","author":"Chan","year":"2024","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.kint.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome","volume":"23","author":"Magnasco","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfu267","article-title":"Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome","volume":"30","author":"Sinha","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2015-0486","article-title":"Mycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndrome","volume":"136","author":"Basu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.kint.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00467-014-2765-z","article-title":"Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome","volume":"29","author":"Kamei","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-021-05345-9","article-title":"Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome","volume":"37","author":"Chan","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/clinchem\/hvab278","article-title":"National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories","volume":"68","author":"Miller","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00467-018-4166-1","article-title":"Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children","volume":"35","author":"Kamei","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00467-015-3120-8","article-title":"Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome","volume":"30","author":"Counsilman","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00467-015-3197-0","article-title":"Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab","volume":"31","author":"Kamei","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib31","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B\u00a0cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fimmu.2019.01653","article-title":"Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome","volume":"10","author":"Colucci","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2024.09.011_bib33","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2215\/CJN.01070118","article-title":"Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis","volume":"13","author":"Mendez","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10157-023-02431-0","article-title":"Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)","volume":"28","author":"Nozu","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00467-020-04788-w","article-title":"When should we start and stop ACEi\/ARB in paediatric chronic kidney disease?","volume":"36","author":"Chan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","article-title":"Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome","volume":"28","author":"Sellier-Leclerc","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/bcp.13548","article-title":"Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome","volume":"84","author":"Bonanni","year":"2018","journal-title":"Br J Clin Pharmcol"},{"key":"10.1016\/j.kint.2024.09.011_bib39","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00467-024-06371-z","article-title":"Rituximab-induced hypogammaglobulinemia in nephrotic syndrome: what is the true burden?","volume":"39","author":"Chan","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s00467-024-06379-5","article-title":"Clinical significance of rituximab-associated hypogammaglobulinemia in nephrotic syndrome: to treat or not to treat?","volume":"39","author":"Chan","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.09.011_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.kint.2022.01.035","article-title":"Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseases","volume":"101","author":"Ma","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.09.011_bib42","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.ekir.2023.08.014","article-title":"Humoral and cellular immunogenicity of 3 doses of BNT162b2 in children with kidney diseases","volume":"8","author":"Leung","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.09.011_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.kint.2024.09.011_bib44","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2215\/CJN.11941115","article-title":"T\u00a0lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS","volume":"11","author":"Chan","year":"2016","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:56:55Z","timestamp":1735315015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824007002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0085253824007002"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.09.011","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}